Myers, R., Li, Y., Liu, H., Hoover, A., Shinehouse, L., Hinson, A., Kohorst, M., Elias, A., Keenan, E., Acres, H., Ahmed, I., Al-Mulla, A., Arthur, L., Beck, J., Berry, A., Bhatla, D., Briscoe, E., Chang, G., Chu, R., Davis, L., Dolan, J. G., Elo, L., Eom, E., Vasco, A. E., Fabrizio, V., Faulk, K., Galan-Gomez, V., Goode, E., Grupp, S., Hall, A., Hamill, D., Vasanna, S., Kinoshita, H., Krieger, E., Lee-Miller, C., Lind, K., Milner, J., Moore-Higgs, G., Moskop, A., Murphy, L., Murphy, M., Nguyen, G., Ortega, M., Patel, H., Perez, A., Pfeiffer, T., Prosser-Dombrowski, A., Rahim, M., Rahrig, A., Ramachandran, S., Hammoud, M. S., Saraf, A., Shoag, J., Symons, H., Tastet, N., Thomas, S., Thornock, M., Toner, K., Weisnicht, A., Zarnegar-Lumley, S., Shah, N., Maude, S., Rubinstein, J., Quigg, T., Bhojwani, D., Elgarten, C. (2025). Optimal therapy for pediatric B-ALL in first relapse: Comparative effectiveness of blinatumomab to hematopoietic cell transplantation versus CD19 CAR T cell therapy. Blood. https://doi.org/10.1182/blood-2025-3339